ImmunityBio Inc
(NAS:IBRX)
$
5.44
0.24 (4.62%)
Market Cap: 3.79 Bil
Enterprise Value: 4.15 Bil
PE Ratio: 0
PB Ratio: 0
GF Score: 28/100 
Immunitybio Inc at Jefferies Healthcare Conference Transcript
Jun 07, 2023 / 02:00PM GMT
Release Date Price:
$3.05
(-7.29%)
Kelly Shi
(Trades, Portfolio) LLC - Analyst
Good morning, everyone. Thank you for attending Jefferies New York Healthcare Conference. And my name is Kelly Shi, one of the biotech analysts here.
And we are very pleased to have Dr. Patrick Soon-Shiong, Executive Chairman and the Global Chief Scientific and Medical Officer. Patrick will start with storytelling of ImmunityBio and what they are working on and we'll start from here. And welcome, Patrick.
Patrick Soon;Shiong
ImmunityBio, Inc. - Chairman
Thank you, Kelly.
Okay. Well, I don't have any slides today, so what we can to be doing is we'll have a Q&A session. This is a forward-looking statement.
And I think as you all know, we're deep into bladder cancer
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers